tetraethylammonium has been researched along with Psychotic Disorders in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Etcheberrigaray, R | 1 |
| Ito, E | 1 |
| Oka, K | 1 |
| Tofel-Grehl, B | 1 |
| Gibson, GE | 1 |
| Alkon, DL | 1 |
1 other study available for tetraethylammonium and Psychotic Disorders
| Article | Year |
|---|---|
Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Calcium; Cell Line; Cells, Cultured; Female; Fibr | 1993 |